1. FRI0217 Impact of rituximab in combination with leflunomide and rituximab retreatment with two different dosages on patient-reported outcomes: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-STUDY). (15th June 2017) Authors: Köhm, M; Rossmanith, T; Dauth, S; Alten, R; Aringer, M; Backhaus, M; Burmester, G; Feist, E; Kellner, H; Krüger, K; Müller-Ladner, U; Rubbert-Roth, A; Tony, H-P; Wassenberg, S; Burkhardt, H; Behrens, F Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗